GPR56 contributes to the development of acute myeloid leukemia in mice von Daria, D, Kirsten, N, Muranyi, A, Mulaw, M, Ihme, S, Kechter, A, Hollnagel, M, Bullinger, L, Döhner, K, Döhner, H, Feuring-Buske, M, Buske, C

Volltext

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD1... von Ferdinandus, J., Müller, H., Damaschin, C., Jacob, A.S., Meissner, J., Krasniqi, F., Mey, U., Schöndube, D., Thiemer, J., Mathas, S., Zijlstra, J., Greil, R., Feuring-Buske, M., Markova, J., Rüffer, J.U., Kobe, C., Eich, H.-T., Baues, C., Fuchs, M., Borchmann, P., Behringer, K.

Volltext

An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia von Herold, T, Jurinovic, V, Metzeler, K H, Boulesteix, A-L, Bergmann, M, Seiler, T, Mulaw, M, Thoene, S, Dufour, A, Pasalic, Z, Schmidberger, M, Schmidt, M, Schneider, S, Kakadia, P M, Feuring-Buske, M, Braess, J, Spiekermann, K, Mansmann, U, Hiddemann, W, Buske, C, Bohlander, S K

Volltext

The leukemogenicity of Hoxa9 depends on alternative splicing von Stadler, C R, Vegi, N, Mulaw, M A, Edmaier, K E, Rawat, V P S, Dolnik, A, Bullinger, L, Heilmeier, B, Quintanilla-Fend, L, Spiekermann, K, Hiddemann, W, Döhner, K, Döhner, H, Feuring-Buske, M, Buske, C

Volltext

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma : A multicenter phase II study von COIFFIER, B, HAIOUN, C, CAPDEVILLE, R, DIEHL, V, REYES, F, KETTERER, N, ENGERT, A, TILLY, H, MA, D, JOHNSON, P, LISTER, A, BUSKE, M. F, RADFORD, J. A

Volltext

AML1-ETO Needs a Partner: New Insights into the Pathogenesis of t(8;21) Leukemia von Kuchenbauer, F., Feuring-Buske, M., Buske, C.

Volltext

The homeobox gene CDX2 is aberrantly expressed and associated with an inferior prognosis in patients with acute lymphoblastic leukemia von Thoene, S, Rawat, V P S, Heilmeier, B, Hoster, E, Metzeler, K H, Herold, T, Hiddemann, W, Gökbuget, N, Hoelzer, D, Bohlander, S K, Feuring-Buske, M, Buske, C

Volltext

Impact of PET‐2 guided treatment de‐escalation on time‐to‐recovery from cancer‐related fatigue in advanced stage Hodgkin Lymphoma: results from the GHSG HD18 study von Ferdinandus, J., Müller, H., Damaschin, C., Jacob, A. S., Meissner, J., Krasniqi, F., Mey, U., Schöndube, D., Thiemer, J., Mathas, S., Zijlstra, J. M., Greil, R., Feuring‐Buske, M., Markova, J., Kobe, C., Eich, H. T., Baues, C., Fuchs, M., Behringer, K., Borchmann, P.

Volltext

The utility of angiography-derived fractional flow reserve in predicting graft occlusions prior to bypass surgery von Buske, M B, El Hadi, H E, Fischer, N F, Thiele, H T, Majunke, N M

Volltext

P-543 Higher maternal age alters the insulin/IGF system and intracellular lipid metabolism of the endometrium and in the preimplantation embryo – insights from the rabbit model von Schindler, M, Thoma, J, Buske, M, De Nivelle, J, Toto Nienguesso, A, Navarrete Santos, A

Volltext

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up von Bellmunt, J, Orsola, A, Leow, J J, Wiegel, T, De Santis, M, Horwich, A

Volltext

EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL von Borchmann, P., Goergen, H., Kobe, C., Eichenauer, D., Greil, R., Lohri, A., Novak, U., Markova, J., Beck, H., Meissner, J., Zijlstra, J.M., Ostermann, H., Feuring‐Buske, M., Dierlamm, J., Eich, H., Baues, C., Rosenwald, A., Fuchs, M., Diehl, V., Kuhnert, G., Dietlein, M., Engert, A.

Volltext

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice von Schessl, Christina, Rawat, Vijay P S, Cusan, Monica, Deshpande, Aniruddha, Kohl, Tobias M, Rosten, Patricia M, Spiekermann, Karsten, Humphries, R Keith, Schnittger, Susanne, Kern, Wolfgang, Hiddemann, Wolfgang, Quintanilla-Martinez, Leticia, Bohlander, Stefan K, Feuring-Buske, Michaela, Buske, Christian

Volltext

AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia von Schneider, F, Bohlander, S K, Schneider, S, Papadaki, C, Kakadyia, P, Dufour, A, Vempati, S, Unterhalt, M, Feuring-Buske, M, Buske, C, Braess, J, Wandt, H, Hiddemann, W, Spiekermann, K

Volltext

Clinical comparison of histamine H1–receptor antagonist drugs von Du Buske, Lawrence M.

Volltext

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas : results of a phase-II study of the German low-grade lymphoma study group von FEURING-BUSKE, M, KNEBA, M, HALLEK, M, AULITZKY, E, HIDDEMANN, W, UNTERHALT, M, ENGERT, A, GRAMATZKI, M, HILLER, E, TRÜMPER, L, BRUGGER, W, OSTERMANN, H, ATZPODIEN, J

Volltext

Towards a pathogenesis-oriented therapy of acute myeloid leukemia von Hiddemann, W., Spiekermann, K., Buske, C., Feuring-Buske, M., Braess, J., Haferlach, T., Schoch, C., Kern, W., Schnittger, S., Berdel, W., Wörmann, B., Heinecke, A., Sauerland, C., Büchner, Th

Volltext

Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors von Feuring-Buske, M, Gerhard, B, Cashman, J, Humphries, R K, Eaves, C J, Hogge, D E

Volltext

Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells von Buske, Christian, Feuring-Buske, Michaela, Abramovich, Carolina, Spiekermann, Karsten, Eaves, Connie J., Coulombel, Laure, Sauvageau, Guy, Hogge, Donna E., Humphries, R. Keith

Volltext

Ectopic Expression of the Homeobox Gene Cdx2 Is the Transforming Event in a Mouse Model of t(12;13)(p13;q12) Acute Myeloid Leukemia von Vijay P. S. Rawat, Cusan, Monica, Deshpande, Aniruddha, Hiddemann, Wolfgang, Quintanilla-Martinez, Leticia, Humphries, R. Keith, Bohlander, Stefan K., Feuring-Buske, Michaela, Buske, Christian

Volltext